{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:16:34Z","timestamp":1788261394062,"version":"build-2803163510"},"reference-count":40,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/17474086.2026.2688872","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:54:12Z","timestamp":1783968852000},"page":"1077-1089","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Myelofibrosis treatment sequencing: mutation-informed risk and optimal JAK inhibitor discontinuation"],"prefix":"10.1080","volume":"19","author":[{"given":"Giulia","family":"Benevolo","sequence":"first","affiliation":[{"name":"Citt\u00e0 della Salute e della Scienza","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lanzarone","sequence":"additional","affiliation":[{"name":"Citt\u00e0 della Salute e della Scienza","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Rosti","sequence":"additional","affiliation":[{"name":"Citt\u00e0 della Salute e della Scienza","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Beggiato","sequence":"additional","affiliation":[{"name":"Citt\u00e0 della Salute e della Scienza","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-485888"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30027-3"},{"key":"e_1_3_4_7_1","first-page":"269","article-title":"Real-world outcomes following ruxolitinib therapy","volume":"401","author":"Mascarenhas J","year":"2023","unstructured":"Mascarenhas J, Gerds AT, Vannucchi AM, et al. Real-world outcomes following ruxolitinib therapy. Lancet. 2023;401:269\u2013280.","journal-title":"Lancet"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32664"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000898"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205027"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2025.107719"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00392-1"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35801"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.4886"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9867"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080813"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.119"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031366"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01673-3"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-554634"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27609"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.4418"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02036-0"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35156"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70457"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70320"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30027-3"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5818"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1590"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30088-1"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00212-6"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00116-8"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03572-3"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173509"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013170"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0901"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012939"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-015-0021-2"},{"key":"e_1_3_4_40_1","unstructured":"Geron Corporation. IMpactMF: a phase 3 study of imetelstat versus best available therapy in relapsed\/refractory myelofibrosis (NCT04576156). ClinicalTrials.gov. [cited 2026 May]."},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-026-02841-0"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00305-8"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2688872","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17474086.2026.2688872","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2688872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:33:20Z","timestamp":1788258800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2688872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/17474086.2026.2688872"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2688872","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}